Clinical Trial Update: Phase III Trial of Sirolimus in IBM [Phase 3]

View source ↗

Summary

Phase III trial of sirolimus in inclusion body myositis is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inclusion Body Myositis

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Inclusion Body Myositis | Phase 3 | Status: ACTIVE_NOT_RECRUITING